Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Dividend Declaration

1 Jul 2026 16:11

RNS Number : 6797K
JPMorgan Emerg Mkts Growth & Income
01 July 2026
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN EMERGING MARKETS GROWTH & INCOME PLC

(the "Company" or "JMGI")

 

FIRST QUARTERLY INTERIM DIVIDEND ANNOUNCEMENT

 

 

Legal Entity Identifier: 5493001VPQDYH1SSSR77Information disclosed in accordance with DTR 6.1.13

 

The Board is pleased to announce that it intends to pay dividends totalling 7.528 pence per share (1.882 pence per share per quarter) in respect of the financial year commencing 1 July 2026. This is in line with the Company's policy of paying 4.0% of JMGI's net asset value as at the preceding financial year end, payable in four equal quarterly instalments.

 

The first interim dividend for the financial year ending 30 June 2027 of 1.882 pence per share will be paid on 14 August 2026 to shareholders on the register at the close of business on 10 July 2026. The ex-dividend date will be 9 July 2026. The three subsequent quarterly dividends are expected to be paid in November 2026February 2027 and May 2027.

 

The Board reiterates that the Company's enhanced dividend policy is not progressive and does not constrain the portfolio managers, nor does it alter JMGI's investment mandate or strategy in any way.

 

The Company offers the option for shareholders to use their cash dividends to purchase additional shares through a Dividend Reinvestment Plan ("DRIP"). For details of the DRIP, please contact the Company's Registrar, Computershare Investor Services plc.

 

The key dates relating to this dividend are set out below:

 

Event

Date

Ex-dividend date

9 July 2026

Record date

10 July 2026

Last DRIP election date

24 July 2026

Payment date

14 August 2026

 

1 July 2026

  

For further information, please contact: Divya AminFor and on behalf of JPMorgan Funds Limited, Secretary0800 20 40 20 (or +44 1268 44 44 70)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEASXFEEPKEFA

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS